Corbus Pharmaceuticals Holdings, Inc. short interest in 2025
In 2025, Corbus Pharmaceuticals Holdings, Inc.'s disclosed short interest ran from 19.68% of shares outstanding on 15 Jan 2025 to 7.49% on 31 Dec 2025, a change of -12.19 percentage points. The year's high was 20.21% on 31 Mar 2025 and its low 5.49% on 14 Nov 2025, averaging 13.03% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 16.48 days on 30 May 2025. Full history: Corbus Pharmaceuticals Holdings, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 19.68% (15 Jan 2025)
- End of year
- 7.49% (31 Dec 2025)
- Change
- -12.19 pp
- High
- 20.21% (31 Mar 2025)
- Low
- 5.49% (14 Nov 2025)
- Average
- 13.03%
- Highest days to cover
- 16.48 (30 May 2025)
- SEC filings marked
- 8
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 19.68% | 14.26 | |
| 31 Jan 2025 | 19.06% | 10.05 | |
| 14 Feb 2025 | 20.04% | 6.92 | |
| 28 Feb 2025 | 19.95% | 10.38 | |
| 14 Mar 2025 | 20.19% | 12.95 | 10-K filed, results (8-K) |
| 31 Mar 2025 | 20.21% | 10.36 | |
| 15 Apr 2025 | 17.48% | 10.81 | |
| 30 Apr 2025 | 15.09% | 11.31 | |
| 15 May 2025 | 15.42% | 15.99 | 10-Q filed, results (8-K) |
| 30 May 2025 | 14.97% | 16.48 | |
| 13 Jun 2025 | 15.28% | 12.70 | |
| 30 Jun 2025 | 12.61% | 5.62 | |
| 15 Jul 2025 | 11.23% | 9.14 | |
| 31 Jul 2025 | 10.15% | 9.69 | |
| 15 Aug 2025 | 9.89% | 12.46 | 10-Q filed, results (8-K) |
| 29 Aug 2025 | 9.48% | 11.31 | |
| 15 Sep 2025 | 9.76% | 16.04 | |
| 30 Sep 2025 | 9.56% | 6.00 | |
| 15 Oct 2025 | 8.05% | 3.77 | |
| 31 Oct 2025 | 8.57% | 1.53 | |
| 14 Nov 2025 | 5.49% | 1.86 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 5.80% | 3.71 | |
| 15 Dec 2025 | 7.34% | 2.04 | |
| 31 Dec 2025 | 7.49% | 5.50 |
See also: Corbus Pharmaceuticals Holdings, Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.